GENEVA, July 1 -- GENZYME CORPORATION filed a patent application (US2025/059424) for “TREATMENT OF HEMOPHILIA WITH FITUSIRAN IN PEDIATRIC PATIENTS”. With publication no. WO/2026/128823, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/713
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....